Tweetovi

Blokirali ste korisnika/cu @DhruvKhullar

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @DhruvKhullar

  1. Prikvačeni tweet

    Excited to share new work : Drug prices are a major concern for Americans. We describe the many levers policymakers have—beyond price negotiation—to reduce the cost burden on patients, while maintaining incentives for the innovation society needs.

    Prikaži ovu nit
    Poništi
  2. proslijedio/la je Tweet
    30. sij

    In a national drug pricing debate begging for nuance, this work and data visualization is 🔥🔥🔥

    Poništi
  3. Reminded of the beauty of 's writing when re-reading this on diagnostic uncertainty: "Possibility is not the same as probability, but when you’re bearing the weight of another person’s life, the distinction often feels meaningless."

    Poništi
  4. Disheartening findings in new report: US spends much more on health care than other developed countries, but has the lowest life expectancy, highest suicide rates, and highest rates of avoidable deaths.

    Poništi
  5. The central insight is that America's drug market is anything but a traditional free market. Lawmakers have constructed every aspect of the system—and thus have many options, beyond price negotiation, to change the calculus for drug innovation & the costs to patients.

    Prikaži ovu nit
    Poništi
  6. Finally, the Competitive Period starts when other companies are allowed to introduce products to compete with the innovator drug. Again, policymakers determine when & how generics can compete—which profoundly influences drug company profits, as patents & exclusivities expire.

    Prikaži ovu nit
    Poništi
  7. If/when a drug is approved, the Monopoly Period begins. This is where the majority of the reward for successful innovation is earned. Policymakers can influence incentives by deciding how long and how thoroughly new drugs should be protected from competition.

    Prikaži ovu nit
    Poništi
  8. In the Innovation Period, drugs are developed & tested. Process is risky but there are many ways to reduce risk & cost without allowing companies to charge exorbitant prices. Question for policymakers is: What is allowed into the market and how much should it cost to get there?

    Prikaži ovu nit
    Poništi
  9. We explore the 3 stage journey every drug makes during its life—and how adjusting the rewards & costs for drugmakers during each period can influence the overall reward for innovation. (The Interactive Graphic lets readers see how each policy influences this reward system.)

    Prikaži ovu nit
    Poništi
  10. proslijedio/la je Tweet
    29. sij

    Just out from et al. The structure of rewards (and costs) in pharmaceutical drug development. We introduce the 'reward box' interactive graphic to see how the elements interplay, how specific policies affect it.

    Prikaži ovu nit
    Poništi
  11. Poništi
  12. proslijedio/la je Tweet
    23. sij

    Treating Regret Excellent article by on the consequences of neglecting regret on everyone and calls on health care providers to recognize the impact of regret on patients and families. /1

    Poništi
  13. proslijedio/la je Tweet

    Regrets, I've had a few: Despite the pervasiveness of regret, doctors often overlook it, by via

    Poništi
  14. Regret is a powerful emotion many patients & clinicians experience, but one that often goes unexplored. In , I discuss how we can work through regret—and focus not on what might have been but on what still is.

    Poništi
  15. proslijedio/la je Tweet
    21. sij

    New descriptive paper with and Zeke Emanuel in examining association between county-level social mobility (a measure of economic opportunity) and life expectancy at age 40: 1/

    Prikaži ovu nit
    Poništi
  16. proslijedio/la je Tweet
    13. sij

    Our new paper (w/ + ): patterns of turnover in the physician workforce likely contribute to provider consolidation. (1/7)

    Prikaži ovu nit
    Poništi
  17. Thanks to the entire team who worked so hard to make this seamless video visit service available to patients. If you, a friend, or a family member want to learn more about treatment options available, please check it out or spread the word.

    Prikaži ovu nit
    Poništi
  18. Excited to announce a new product : our cancer video concierge service. In a few clicks, newly-diagnosed breast cancer patients can schedule a free, personalized video visit with our fantastic RNs & learn about onc care available

    Prikaži ovu nit
    Poništi
  19. Today my computer broke, so I had to write by hand and it was the most productive day I've had in months, but now my computer is working again, so I'm sending this tweet.

    Poništi
  20. proslijedio/la je Tweet
    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·